2021
DOI: 10.4103/jfmpc.jfmpc_1475_20
|View full text |Cite
|
Sign up to set email alerts
|

Acute psychosis as the presenting manifestation of lupus

Abstract: Neuropsychiatric manifestations like cognitive dysfunction, peripheral neuropathy, stroke headache, seizures in systemic lupus erythematosus (SLE) are quite common. However, psychosis as the sole presenting manifestation of SLE is rarely encountered clinically. If lupus is not kept as differential among patients with acute psychosis, delay in diagnosis and subsequent mismanagement are likely to happen. Here, we present a case of a young female presenting with acute psychosis as the predominant symptom and was … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(13 citation statements)
references
References 24 publications
0
12
0
1
Order By: Relevance
“…Antidepressants and anxiolytics are also often used, and their use reported positive outcomes in improving cognitive functions in SLE patients with anxiety and depression; however, their use in mood disorders is variable [ 37 ]. The use of antiepileptics for seizures in SLE has shown favorable efficacy, and antipsychotics are used for SLE psychosis [ 38 , 39 ]. Cognitive dysfunction in SLE is managed with a meta context behavioral rehabilitation strategy.…”
Section: Reviewmentioning
confidence: 99%
See 1 more Smart Citation
“…Antidepressants and anxiolytics are also often used, and their use reported positive outcomes in improving cognitive functions in SLE patients with anxiety and depression; however, their use in mood disorders is variable [ 37 ]. The use of antiepileptics for seizures in SLE has shown favorable efficacy, and antipsychotics are used for SLE psychosis [ 38 , 39 ]. Cognitive dysfunction in SLE is managed with a meta context behavioral rehabilitation strategy.…”
Section: Reviewmentioning
confidence: 99%
“…However, NSAID use in SLE is associated with an increased incidence of recurrent aseptic meningitis [ 43 ]. Ischemic NPSLE is managed with anticoagulation and antiplatelet therapy, particularly if the patients have positive antiphospholipid antibodies [ 39 ]. In most patients, inflammatory and ischemic NPSLE coexist; authors suggest using a combination of therapies, including immunosuppressive, anticoagulation, and antiplatelet therapy [ 35 ].…”
Section: Reviewmentioning
confidence: 99%
“…Neuropsychiatric manifestations in SLE may be due to the disease itself or drugs used to treat it (glucocorticoids, Chloroquine) or exacerbation of pre-morbid psychiatric condition [ 10 , 11 ]. These include acute confusional state, psychosis, mood symptoms, anxiety disorder, seizures, cognitive dysfunction, delirium, headache, movement disorder, etc [ 12 , 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…Likewise, the former is found to be associated with high level of antibodies to p-ribosomal proteins, increase in cerebrospinal fluid IL-6, serum anti Sm antibody and antiphospholipid antibodies [ 18 ]. Study of steroid dosage (prednisolone equivalent>40 mg/day), time interval (within one to two weeks of initiation of therapy) and duration of mental changes (improvement with tapering of steroids) can be helpful [ 10 , 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…Anxiolytics and antidepressants are also used to improve cognitive skills in SLE patients with anxiety and depression; however, their use in mood disorders is inconsistent [106]. Effective antiepileptics and antipsychotics are used to treat SLE psychosis and seizures, respectively [107,108]. The cognitive dysfunction caused by SLE is managed to utilize a technique known as meta-context behavioral rehabilitation.…”
Section: Management and Treatmentmentioning
confidence: 99%